UNILEVER PLC
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2025 · Filed Mar 12, 2026
Use the contents to explore the available documents and sections.
Contents
DIRECTORS’ RESPONSIBILITY STATEMENT
Under company law, the directors must not approve the financial statements
unless they are satisfied that they give a true and fair view of the state of affairs
of the Group and parent company and of the Group’s profit or loss for that period.
Under applicable law and regulations, the directors are also responsible for
preparing a Strategic Report, Directors’ Report, Directors’ Remuneration Report
and Corporate Governance Statement that complies with that law and those
regulations.
Each of the Directors confirms that, to the best of his or her knowledge:
■The Unilever Annual Report and Accounts 2025, taken as a whole, is fair,
balanced and understandable, and provides the information necessary for
shareholders to assess the Company’s position and performance, business
model and strategy;
■The Financial Statements, which have been prepared in accordance
with International Financial Reporting Standards (IFRS) as issued by
the International Accounting Standards Board (IASB), and UK-adopted
international accounting standards, give a true and fair view of the assets,
liabilities, financial position and profit or loss of the Company and the
undertakings included in the consolidation taken as a whole; and
■The Management Report includes a fair review of the development
and performance of the business and the position of PLC and the
undertakings included in the consolidation taken as a whole, together with a
description of the principal risks and uncertainties that they face.
The Directors and their roles are listed on pages 52 to 55.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.